Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-18

Clinical Trial Update: Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

View source ↗

Summary

A Boston Children's Hospital-led clinical study investigates why atopic dermatitis patients with the IL-4Ra R576 polymorphism have more severe disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Children's Hospital | Conditions: Atopic Dermatitis | Status: RECRUITING